Close Menu
Newsoutnow.comNewsoutnow.com
    Quick Access
    • Bigg-Boss
    • Entertainment
    • High Life
    • Infotainment
    • News
      • Business
      • Sports
      • Technology
    • News Wire
    • Photo Gallery
    • Stars-Wiki
    • Trending
    • World
    Facebook X (Twitter) Instagram
    • About
    • Download the App
    • Contact Us
    Facebook X (Twitter) Pinterest
    Newsoutnow.comNewsoutnow.com
    • Entertainment
    • Infotainment
    • News
      • Sports
      • Business
      • Technology
      • World
    • High Life
    • Trending
    Newsoutnow.comNewsoutnow.com
    Home»News Wire»DOJ Drops All Charges Against Vasudha
    News Wire

    DOJ Drops All Charges Against Vasudha

    PR NewswireBy PR NewswireApril 17, 20263 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Reddit Telegram Email
    Share
    Facebook Twitter LinkedIn Pinterest Email

    The company welcomes dismissal of the case after maintaining its innocence for more than a year HYDERABAD, India, April 16, 2026 /PRNewswire/ — Vasudha Pharma Chem Limited (“Vasudha” or the “Company”), a leading pharmaceutical bulk drug and intermediate manufacturing company, announced today that on March 26, 2026, it entered into a Non-Prosecution Agreement (the “Agreement”) with the U.S. Department of Justice (“DOJ”). All charges previously brought against Vasudha were dismissed, the Company was not found guilty of any crime, and there are no longer any outstanding criminal or civil charges against the Company. Vasudha has maintained its innocence from the beginning.
    “All of us at Vasudha welcome the resolution of this matter,” said M Ashok Srinivas Raju, Executive Director. “We are a family of dedicated chemists, chemical engineers, and scientists, and every employee at this company is committed to the responsible and ethical creation of critical pharmaceutical products that help medical patients around the world.”Anand Mantena, Executive Director, added, “We are very pleased that all charges have been dropped against the company, and that this issue is now resolved. We are back to business as usual and look forward to continuing to serve our customers with the highest degree of care.”The DOJ recognized that the Company has no prior criminal history or history of regulatory actions against it and credited Vasudha for its cooperation with the investigation. Vasudha, for its part, has already enhanced its compliance program and internal controls, and has committed to making future enhancements.”We are pleased that the DOJ agreed to dismiss all charges against Vasudha,” said Glen McGorty, former federal prosecutor in the Southern District of New York and Managing Partner of leading international law firm Crowell & Moring’s New York City office. “Vasudha has acted with dignity and total transparency with the DOJ, and we are proud to have represented them and to have achieved such a positive result.”Vasudha Pharma Chem Limited Vasudha is a well-established, community-oriented, family-owned company that has operated in the pharmaceutical industry with a clean record for over thirty years. The Company proudly serves customers in over 90 countries including multinational corporations and pharmaceutical companies in the United States, Europe, and LATAM. Vasudha’s facilities are accredited by the U.S. Food and Drug Administration and equivalent agencies in Europe, Japan, and Brazil, and the Company maintains a strong, cooperative relationship with the Central Bureau of Narcotics in India.The company employs more than 4,000 employees and contractors and has been identified among the top 5% of Indian companies by the Ministry of Corporate Affairs, Government of India for its “excess” Corporate Social Responsibility expenditures (spending more than required on social responsibility measures). Along with its long-recognized dedication to its employees and work culture, Vasudha is a profoundly charitable company, which has pledged 30% of its wealth to philanthropic activities through the founding family’s charitable foundation, VRVV Family Vasudha Foundation.

    View original content:https://www.prnewswire.com/in/news-releases/doj-drops-all-charges-against-vasudha-302745185.html

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Previous ArticleDXC Expands Consulting & Engineering Services Leadership to Scale AI-led Growth
    Next Article How IBM Quantum is Enabling Healthcare and Biology Research
    PR Newswire
    PR Newswire

    PR Newswire is a distributor of press releases headquartered in New York City.

    Next Up For You

    News Wire

    As Food Traditions Vanish, World Food Travel Association Launches World Culinary Heritage Day to Help Preserve Endangered Culinary Traditions

    April 17, 2026
    News Wire

    How IBM Quantum is Enabling Healthcare and Biology Research

    April 17, 2026
    News Wire

    DXC Expands Consulting & Engineering Services Leadership to Scale AI-led Growth

    April 17, 2026
    News Wire

    VerifiedX Launches the First Native Bitcoin and VFX Privacy Transactions, Introducing Confidential Financial Infrastructure for Institutions and Everyone

    April 16, 2026
    News Wire

    Milliken & Company Releases 2025 Sustainability Report

    April 16, 2026
    News Wire

    Firstsource Launches Kairos — The Operating System Powering Intelligence That Operates

    April 16, 2026
    More Reads

    Bain Capital Opens Office in Abu Dhabi, Deepening Long-Term Commitment to the Middle East

    April 16, 2026

    Remote People Named Best Employer of Record for 2026 by Outsource Accelerator

    April 16, 2026

    PHANTASTICUS PICTURES ANNOUNCES THE INTERNATIONAL RELEASE OF VANTARA: SANCTUARY STORIES, PREMIERING ON DISCOVERY INTERNATIONAL PLATFORMS THIS SPRING

    April 16, 2026

    NYSE Content Update: Madison Air Raises More than $2.2 Billion in its IPO

    April 16, 2026

    Mount Sinai Health System and SOPHiA GENETICS Announce Collaboration to Advance Precision Cancer Care from AACR 2026

    April 16, 2026

    HR Path Strengthens Global Presence with Strategic Acquisition of GDT Brasil

    April 16, 2026

    Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services Collaborate to Support ADC Development and Manufacturing

    April 16, 2026
    Facebook X (Twitter) Pinterest RSS
    • About
    • Download the App
    • Contact Us
    © 2026 newsoutnow.com

    Type above and press Enter to search. Press Esc to cancel.